SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001564590-21-024202
Filing Date
2021-05-05
Accepted
2021-05-05 17:16:12
Documents
48
Period of Report
2021-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q tcon-10q_20210331.htm 10-Q 1711028
2 EX-31.1 tcon-ex311_6.htm EX-31.1 9090
3 EX-31.2 tcon-ex312_11.htm EX-31.2 9059
4 EX-32.1 tcon-ex321_7.htm EX-32.1 5401
5 EX-32.2 tcon-ex322_10.htm EX-32.2 5342
  Complete submission text file 0001564590-21-024202.txt   5469640

Data Files

Seq Description Document Type Size
6 XBRL INSTANCE DOCUMENT tcon-20210331.xml EX-101.INS 1083159
7 XBRL TAXONOMY EXTENSION SCHEMA tcon-20210331.xsd EX-101.SCH 46605
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE tcon-20210331_cal.xml EX-101.CAL 29397
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE tcon-20210331_def.xml EX-101.DEF 140264
10 XBRL TAXONOMY EXTENSION LABEL LINKBASE tcon-20210331_lab.xml EX-101.LAB 321204
11 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE tcon-20210331_pre.xml EX-101.PRE 231415
Mailing Address 4350 LA JOLLA VILLAGE DRIVE SUITE 800 San Diego CA 92122
Business Address 4350 LA JOLLA VILLAGE DRIVE SUITE 800 San Diego CA 92122 858-550-0780
Tracon Pharmaceuticals, Inc. (Filer) CIK: 0001394319 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-36818 | Film No.: 21894561
SIC: 2836 Biological Products, (No Diagnostic Substances)